Fintel reports that on December 10, 2024, RBC Capital downgraded their outlook for BrightSphere Investment Group (NYSE:BSIG) ...

RBC Capital analyst Gregory Renza maintained a Hold rating on Spruce Biosciences (SPRB – Research Report) yesterday and set a price target of ...

In a report released yesterday, Jonathan Atkin from RBC Capital maintained a Buy rating on Equinix (EQIX – Research Report), with a price ...

Mobileye Global (MBLY) stock rose about 6% on Monday after RBC Capital said that the company could be close to winning a ...

RBC Capital Markets upgrades Marsh & McLennan stock to Outperform, citing strong growth potential and valuation compared to peers.

Find insight on Novo Nordisk, Hikma Pharmaceuticals, Sonic Healthcare and more in the latest Market Talks covering the Health ...

Analysts raise Ollie's price targets, citing strong earnings, unit growth, and market share potential despite challenges.

Exxon Mobil Corp. will raise capital spending next year as it adds the $60 billion purchase of Pioneer Natural Resources Co.

Applied Therapeutics Inc (APLT) stock saw a decline, ending the day at $1.21 which represents a decrease of $-0.03 or -2.42% from the prior close of $1.24. The stock opened at $1.22 and touched a low ...

From M&A and tariffs to new health leaders, here are the top issues for the medical device industry to watch when ...

Despite these concerns, RBC noted that the market reaction has been disproportionate, with TotalEnergies’ market ...

It’s a first among bank-owned discount brokers in Canada. With more banks likely to follow RBC's lead, what should Canadians ...